Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LENZ Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 3.33K | $6.93K | $2.08 | Dec 16, 2024 | Direct |
LENZ Therapeutics, Inc. | Chief Commercial Officer | Stock Option (right to buy) | 64.6K | Dec 16, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LENZ | LENZ Therapeutics, Inc. | Dec 16, 2024 | 2 | $6.93K | 4 | Dec 17, 2024 | Chief Commercial Officer |
LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 4 | $0 | 4 | Mar 25, 2024 | Chief Commercial Officer |
LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 0 | $0 | 3 | Mar 25, 2024 | Chief Commercial Officer |